ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,279,632 | -35.6% | 1,263,825 | 0.0% | 0.05% | -47.8% |
| Q4 2022 | $11,298,596 | -38.6% | 1,263,825 | -2.3% | 0.09% | -23.1% |
| Q3 2022 | $18,396,000 | -18.4% | 1,293,670 | -16.2% | 0.12% | -11.4% |
| Q2 2022 | $22,538,000 | -26.9% | 1,543,670 | 0.0% | 0.13% | -5.0% |
| Q1 2022 | $30,827,000 | +15.4% | 1,543,670 | +1.1% | 0.14% | +39.0% |
| Q4 2021 | $26,712,000 | – | 1,527,273 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |